Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report

Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report

<p>Abstract</p> <p>Background</p> <p>Bortezomib (Velcade<sup>®</sup>), a dipeptide boronate proteasome inhibitor, is a novel anti-cancer agent registered for multiple myeloma (MM). It has also shown promising clinical activity in non-small cell lung cancer (...

Full description

Bibliographic Details
Main Authors:	Giaccone Giuseppe, Voortman Jens
Format:	Article
Language:	English
Published:	BMC 2006-05-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/6/129

Similar Items

The proteasomal and apoptotic phenotype determine bortezomib sensitivity of non-small cell lung cancer cells
by: Chęcińska Agnieszka, et al.
Published: (2007-11-01)

Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling
by: Giaccone Giuseppe, et al.
Published: (2009-09-01)

Response of Bortezomib Chemotherapy in Hepatic Amyloidosis
by: Syed M. Hasan MD, et al.
Published: (2018-03-01)

Case Report on Renal Failure Reversal in Lambda Chain Multiple Myeloma with Bortezomib and Dexamethasone
by: Bhanu K. Patibandla, et al.
Published: (2014-01-01)

Remission of Severe, Relapsed, and Refractory TTP after Multiple Cycles of Bortezomib
by: Manu R. Pandey, et al.
Published: (2017-01-01)

Effectiveness of Bortezomib in Cardiac AL Amyloidosis: A Report of Two Cases
by: Santi Nigrelli, et al.
Published: (2014-01-01)

Reversal of bortezomib resistance in myelodysplastic syndrome cells by MAPK inhibitors.
by: Yingxing Yue, et al.
Published: (2014-01-01)

Severe Organizing Pneumonia after Two Cycles of Docetaxel as Fourth-Line Chemotherapy for Advanced Non-Small Cell Carcinoma of the Lung
by: Jens Hasskarl, et al.
Published: (2009-02-01)

MicroRNA expression and clinical outcome of small cell lung cancer.
by: Jih-Hsiang Lee, et al.
Published: (2011-01-01)

Partially reversible bortezomib-induced cardiotoxicity: an unusual cause of acute cardiomyopathy
by: Marcelle G. Meseeha, et al.
Published: (2015-12-01)

Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib- based chemotherapy
by: Zhao J, et al.
Published: (2015-06-01)

Impact of chemotherapy in the prognosis of non-small-cell lung cancer patients with severe to very severe COPD
by: Dong W, et al.
Published: (2018-11-01)

Acute Reversible Heart Failure Caused by Coronary Vasoconstriction due to Continuous 5-Fluorouracil Combination Chemotherapy
by: Cornelia Dechant, et al.
Published: (2012-06-01)

Experimental Study on the Mechanism of Reversal of Leukemia Multidrug Resistance by Proteasome Inhibitor Bortezomib
by: Ying-chun LI, et al.
Published: (2010-08-01)

Efficacy of Cetuximab in Combination with Chemotherapy in Advanced Non-small Cell Lung Cancer
by: Sheng YANG, et al.
Published: (2016-05-01)

Inhibition of 26S proteasome by Bortezomib enhances chemo drug-mediated cell toxicity in small cell lung cancer
by: Yen, Yi-Xiang, et al.
Published: (2014)

Successful bronchial arterial infusion chemotherapy combined with radiotherapy for an endobronchial metastasis after resection of small cell lung cancer
by: Yoshitsugu Horio, et al.
Published: (2021-04-01)

Combined Effect of Bortezomib and Menadione Sodium Bisulfite on Proteasomes of Tumor Cells: The Dramatic Decrease of Bortezomib Toxicity in a Preclinical Trial
by: Tatiana M. Astakhova, et al.
Published: (2018-09-01)

The Synergistic Antitumor Activity of Chidamide in Combination with Bortezomib on Gastric Cancer
by: Zhang W, et al.
Published: (2020-05-01)

New bortezomib-based combination therapy for elimination of myeloma cells
by: Voll RE, et al.
Published: (2009-02-01)

Alectinib re-challenge in small cell lung cancer transformation after chemotherapy failure in a patient with ALK-positive lung cancer: A case report
by: Akira Yamagata, et al.
Published: (2021-01-01)

Co-delivery of docetaxel and bortezomib based on a targeting nanoplatform for enhancing cancer chemotherapy effects
by: Junpeng Nie, et al.
Published: (2017-01-01)

Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma
by: Diego Cortinovis, et al.
Published: (2021-03-01)

Oligorecurrence Non–small Cell Lung Cancer After Failure of First-Line Chemotherapy: Computed Tomography–Guided 125I Seed Implantation vs. Second-Line Chemotherapy
by: Hao Wang, et al.
Published: (2020-04-01)

CHEMOTHERAPY IN COMBINED MODALITY TREATMENT FOR LOCALLY ADVAMCED NON-SMALL CELL LUNG CANCER
by: Е. L. Yumov, et al.
Published: (2016-02-01)

Cisplatin, Etoposide, and Vincristine Combination Chemotherapy in the Treatment of Non-Small Cell Lung Cancer
by: SAITO, HIDEHIKO, et al.
Published: (1993)

Dramatic Response to Teriprilumab and Anlotinib Combination Therapy in a patient with EGFR-Mutant Lung Adenocarcinoma Who Experienced Small-Cell Transformation−Mediated Erlotinib Resistance After Failure of Chemotherapy
by: Yuling Zhou, MS, et al.
Published: (2020-06-01)

Chemotherapy Reverses Anti-PD-1 Resistance in One Patient With Advanced Non-small Lung Cell Cancer
by: Lingdi Zhao, et al.
Published: (2020-04-01)

Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy
by: Omersa Daniel, et al.
Published: (2016-02-01)

Bortezomib in Kidney Transplantation
by: Rajeev Raghavan, et al.
Published: (2010-01-01)

Effectiveness of bortezomib and bortezomib-containing programs FOR the treatment of recurrent and resistant multiple myeloma
by: T A Mitina, et al.
Published: (2010-07-01)

Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children
by: NA Batmanova, et al.
Published: (2017-07-01)

Busulfan plus melphalan melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma
by: Songyi Park, et al.
Published: (2021-05-01)

Radiofrequency deep hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer
by: Wen-Hui Yang, et al.
Published: (2019-04-01)

Bevacizumab Combined with Chemotherapy for Advanced Non-small Cell Lung Cancer: A meta-analysis
by: Tao ZHANG, et al.
Published: (2013-02-01)

Rapid improvement in renal function in patients with multiple myeloma and renal failure treated with bortezomib
by: Qayum Abdul, et al.
Published: (2010-01-01)

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
by: Yu-Shui Ma, et al.
Published: (2021-09-01)

Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?
by: Kus T, et al.
Published: (2015-06-01)

Cardiac Sarcoidosis Culminating in Severe Biventricular Failure
by: Takefumi Ozaki, et al.
Published: (2009-01-01)

Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
by: Denise Niewerth, et al.
Published: (2016-09-01)